Population pharmacokinetics of tenofovir in HIV/HBV co-infected patients

• Main Authors: Baralee Punyawudho, Narukjaporn Thammajaruk, Parawee Thongpeang, Gail Matthews, Sharon R. Lewin, David Burger, Kiat Ruxrungtham, Anchalee Avihingsanon
• Format: Journal
• Published: 2018
• Subjects: Agricultural and Biological Sciences
• Online Access: https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=84946720638&origin=inward; http://cmuir.cmu.ac.th/jspui/handle/6653943832/44118
• Institution: Chiang Mai University

© 2015 Dustri-Verlag Dr. K. Feistle. Objective: Tenofovir is an efficacious drug with a long half-life and high activity against both HIV and HBV. However, the pharmacokinetics of tenofovir have not been studied in HIV/HBV co-infected patients. Data from HIV mono-infected patients may not be transfe...